Follow
Linda M. Pilarski
Linda M. Pilarski
Professor, Dept Oncology, University of Alberta and Cross Cancer Institute
Verified email at ualberta.ca
Title
Cited by
Cited by
Year
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
R Fonseca, PL Bergsagel, J Drach, J Shaughnessy, N Gutierrez, ...
Leukemia 23 (12), 2210-2221, 2009
11882009
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ...
Leukemia 26 (1), 149-157, 2012
10102012
Genetics and cytogenetics of multiple myeloma: a workshop report
R Fonseca, B Barlogie, R Bataille, C Bastard, PL Bergsagel, M Chesi, ...
Cancer research 64 (4), 1546-1558, 2004
9392004
In multiple myeloma, t (4; 14)(p16; q32) is an adverse prognostic factor irrespective of FGFR3 expression
JJ Keats, T Reiman, CA Maxwell, BJ Taylor, LM Larratt, MJ Mant, ...
Blood, The Journal of the American Society of Hematology 101 (4), 1520-1529, 2003
4972003
International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment
MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ...
Journal of Clinical Oncology 34 (13), 1544-1557, 2016
4432016
In Vitro and in Vivo Targeting of Immunoliposomal Doxorubicin to Human B-Cell Lymphoma
DE Lopes de Menezes, LM Pilarski, TM Allen
Cancer research 58 (15), 3320-3330, 1998
4211998
The breast mucin MUC1 as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer
LH Regimbald, LM Pilarski, BM Longenecker, MA Reddish, ...
Cancer research 56 (18), 4244-4249, 1996
2961996
Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group
J Laubach, L Garderet, A Mahindra, G Gahrton, J Caers, O Sezer, ...
Leukemia 30 (5), 1005-1017, 2016
2922016
Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event.
HM Serra, JF Krowka, JA Ledbetter, LM Pilarski
Journal of immunology (Baltimore, Md.: 1950) 140 (5), 1435-1441, 1988
2691988
RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability
CA Maxwell, JJ Keats, M Crainie, X Sun, T Yen, E Shibuya, M Hendzel, ...
Molecular biology of the cell 14 (6), 2262-2276, 2003
2512003
In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain [published erratum appears …
PL Bergsagel, AM Smith, A Szczepek, MJ Mant, AR Belch, LM Pilarski
2251995
Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer
S Adamia, CA Maxwell, LM Pilarski
Current Drug Targets-Cardiovascular & Hematological Disorders 5 (1), 3-14, 2005
2222005
Overexpression of transcripts originating from the MMSET locus characterizes all t (4; 14)(p16; q32)-positive multiple myeloma patients
JJ Keats, CA Maxwell, BJ Taylor, MJ Hendzel, M Chesi, PL Bergsagel, ...
Blood 105 (10), 4060-4069, 2005
2002005
A combined dielectrophoresis, traveling wave dielectrophoresis and electrorotation microchip for the manipulation and characterization of human malignant cells
EG Cen, C Dalton, Y Li, S Adamia, LM Pilarski, KVIS Kaler
Journal of microbiological methods 58 (3), 387-401, 2004
1892004
Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice
LM Pilarski, G Hipperson, K Seeberger, E Pruski, RW Coupland, ...
Blood, The Journal of the American Society of Hematology 95 (3), 1056-1065, 2000
1792000
A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single …
AJ Szczepek, K Seeberger, J Wizniak, MJ Mant, AR Belch, LM Pilarski
Blood, The Journal of the American Society of Hematology 92 (8), 2844-2855, 1998
1791998
CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications
SP Treon, LM Pilarski, AR Belch, A Kelliher, FI Preffer, Y Shima, ...
Journal of immunotherapy 25 (1), 72-81, 2002
1742002
Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone
SP Treon, JA Mollick, M Urashima, G Teoh, D Chauhan, A Ogata, N Raje, ...
Blood, The Journal of the American Society of Hematology 93 (4), 1287-1298, 1999
1711999
A requirement for antigen-specific helper T cells in the generation of cytotoxic T cells from thymocyte precursors.
LM Pilarski
The Journal of experimental medicine 145 (3), 709-725, 1977
1681977
Monoclonal circulating B cells in multiple myeloma: a continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules
LM Pilarski, GS Jensen
Hematology/oncology clinics of North America 6 (2), 297-322, 1992
1651992
The system can't perform the operation now. Try again later.
Articles 1–20